• Home
  • About
    • Management Team
    • Board of Managers
    • Contact Us
  • Science
    • Pipeline
    • Discovery and Research
  • Healthcare Professionals
    • Medical Information and Resources
    • Products
      • Ribasphere® RibaPak®
        (ribavirin, USP) Tablets
      • INFERGEN®
        (Interferon alfacon-1)
      • Ribasphere® (ribavirin, USP)
        Tablets and Capsules
    • Kadmon Assistance
      • Aspire® Patient Support Program
      • CoPay Savings Programs
  • Patients
    • Products
      • Ribasphere® RibaPak®
        (ribavirin, USP) Tablets
      • INFERGEN®
        (Interferon alfacon-1)
      • Ribasphere® (ribavirin, USP)
        Tablets and Capsules
    • Kadmon Assistance
      • Aspire® Patient Support Program
      • CoPay Savings Programs
    • Information and Resources
      • About Hepatitis C
      • Advocacy Groups
  • Media
    • Press Releases
    • Events
    • Media Contact
By challenging how we develop treatments for serious diseases today, Kadmon is developing the cures of tomorrow.

News

January 10, 2012

Kadmon and Chiromics Announce Licensing Agreement for Ground-breaking Chemical Compounds Library

January 9, 2012

Kadmon Acquires First-in-Class Ras Antagonist from Concordia Pharmaceuticals

See more news »

Events

January 11, 2012

J.P. Morgan Healthcare Conference

See more events »

California Declaration of Compliance

©2012 Kadmon Corporation, LLC, All Rights Reserved.  •  Privacy Policy  •  Terms of Use  •  Contact Us